UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research

被引:60
|
作者
Nassar, Ala F. [1 ,2 ]
Wu, Terence [3 ]
Nassar, Samuel F. [4 ,5 ]
Wisnewski, Adam V. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[2] Univ Connecticut, Dept Chem, 55 North Eagleville Rd, Storrs, CT USA
[3] Yale Univ, West Campus Analyt Core, West Haven, CT USA
[4] Yale Sch Med, Dept Neurol, New Haven, CT 06511 USA
[5] Yale Sch Med, Dept Immunobiol, New Haven, CT 06511 USA
关键词
MASS-SPECTROMETRY; DRUG DISCOVERY; CRITICAL PATH; METABOLISM; STRATEGIES; BIOMARKERS; ACID; METABONOMICS; CONSORTIUM; SARCOSINE;
D O I
10.1016/j.drudis.2016.11.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolomics is a relatively new and rapidly growing area of post-genomic biological research. As use of metabolomics technology grows throughout the spectrum of drug discovery and development, and its applications broaden, its impact is expanding dramatically. This review seeks to provide the reader with a brief history of the development of metabolomics, its significance and strategies for conducting metabolomics studies. The most widely used analytical tools for metabolomics: NMR, LC-MS and GC-MS, are discussed along with considerations for their use. Herein, we will show how metabolomics can assist in pharmaceutical research studies, such as pharmacology and toxicology, and discuss some examples of the importance of metabolomics analysis in research and development.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [1] UPLC-MS in metabolomics: from toxicology to disease diagnosis
    Want, E.
    FEBS JOURNAL, 2012, 279 : 37 - 37
  • [2] Metabolomics study of flavonoids in Coreopsis tinctoria of different origins by UPLC-MS/MS
    Wang, Yi
    Cheng, Junsen
    Jiang, Wei
    Chen, Shu
    PEERJ, 2022, 10
  • [3] An improved detection and identification strategy for untargeted metabolomics based on UPLC-MS
    Hou, Yuanlong
    He, Dandan
    Ye, Ling
    Wang, Guangji
    Zheng, Qiuling
    Hao, Haiping
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 191
  • [4] Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS
    Rui Wang
    Huaixing Kang
    Xu Zhang
    Qing Nie
    Hongling Wang
    Chaojun Wang
    Shujun Zhou
    BMC Cancer, 22
  • [5] Metabolomics analysis of the serum from children with urolithiasis using UPLC-MS
    Wen, Junxiang
    Cao, Yinyin
    Li, Yang
    Zhu, Fenhua
    Yuan, Meifen
    Xu, Jin
    Li, Jian
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1327 - 1337
  • [6] Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS
    Wang, Rui
    Kang, Huaixing
    Zhang, Xu
    Nie, Qing
    Wang, Hongling
    Wang, Chaojun
    Zhou, Shujun
    BMC CANCER, 2022, 22 (01)
  • [7] Development and Validation of Novel UPLC-MS/MS Method for the Analysis of Macitentan in Pharmaceutical Formulations
    Albayrak, Mevlut
    Atila, Alptug
    CURRENT PHARMACEUTICAL ANALYSIS, 2019, 15 (05) : 554 - 559
  • [8] P 27: Impact of targeted UPLC-MS/MS metabolomics on chemical and biochemical characterisation of MAPs
    Martens, Stefan
    Sarrou, Eirini
    Chatzopoulou, Paschalina
    6TH INTERNATIONAL SYMPOSIUM BREEDING RESEARCH ON MEDICINAL AND AROMATIC PLANTS (BREEDMAP 6), 2016, 453 : 169 - 171
  • [9] Identification of anthocyanins in the fruits of Kadsura coccinea using UPLC-MS/MS-based metabolomics
    Huang, Ding
    Ming, Ruhong
    Yao, Shaochang
    Li, Liangbo
    Huang, Rongshao
    Tan, Yong
    BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2021, 98
  • [10] UPLC-MS/MS-based serum metabolomics analysis for comprehensive pathological myopia profiling
    Liu, Xin
    Wu, Yue
    Liu, Yuying
    Qian, Wenzhe
    Huang, Liandi
    Wu, Yixiang
    Ke, Bilian
    EXPERIMENTAL EYE RESEARCH, 2025, 251